scholarly journals Heme oxygenase-1 deficiency affects bone marrow niche and triggers premature exhaustion of hematopoietic stem cells.

2018 ◽  
Author(s):  
Krzysztof Szade ◽  
Monika Zukowska ◽  
Agata Szade ◽  
Witold N Nowak ◽  
Maciej Ciesla ◽  
...  

While intrinsic changes in aging hematopoietic stem cells (HSCs) are well-characterized, it remains unclear how hematopoietic niche affects HSC aging. Here, we demonstrate that cells in the niche - endothelial cells (ECs) and CXCL12-abundant reticular cells (CARs) - highly express the heme-degrading enzyme, heme oxygenase 1 (HO-1), but then decrease its expression with age. RNA-sequencing shows that ECs and CARs from HO-1-deficient animals (HO-1-/-) produce less hematopoietic factors. Consequently, HSCs from young HO-1-/- animals lose quiescence and regenerative potential. Young HO-1-/- HSCs exhibit features of premature aging on the transcriptional and functional level. HO-1+/+ HSCs transplanted into HO-1-/- recipients exhaust their regenerative potential early and do not reconstitute secondary recipients. In turn, transplantation of HO-1-/- HSCs to the HO-1+/+ recipients recovers the regenerative potential of HO-1-/- HSCs and reverses their transcriptional alterations. Thus, HSC-extrinsic activity of HO-1 prevents HSCs from premature aging and may restore the function of aged HSCs.

EMBO Reports ◽  
2019 ◽  
Vol 21 (2) ◽  
Author(s):  
Krzysztof Szade ◽  
Monika Zukowska ◽  
Agata Szade ◽  
Witold Nowak ◽  
Izabella Skulimowska ◽  
...  

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1353-1353
Author(s):  
Yu-An Cao ◽  
Amy J. Wagers ◽  
Holger Karsunky ◽  
Hui Zhao ◽  
Robert Reeves ◽  
...  

Abstract Hematopoietic stem cells (HSCs) must be able to balance their self-renewal and differentiation activities in order to preserve their compartment in response to hematopoietic insults for efficient and life-long hematopoiesis while ensuring sufficient blood production to meet the increased hematopoietic demand. Mechanism(s) that regulate this balance during stress hematopoiesis remain to be fully understood. Heme oxygenase 1 (HO-1) is an important stress-inducible protein and a key enzyme of heme degradation that produces iron, bilirubin, and carbon monoxide (CO). CO is a gaseous regulator of cellular responses to a variety of insults. HO-1 deficiency results in reduced stress defense due to inadequate levels of its products. We report here that mice lacking one allele of HO-1 (HO-1−/+ mice) recovered more rapidly from myelotoxic injury and that sufficient HO-1−/+ bone marrow (BM) transplants engrafted lethally irradiated hosts with accelerated kinetics. These effects of HO-1 deficiency on regenerative hematopoiesis were associated with accelerated cell division of lineage-depleted (lin-) Sca-1+ cells. However, in other experimental settings, the converse can be seen in HO-1 deficiency. Repeated treatment of HO-1−/+ mice with 5-FU significantly reduced the number of HSCs in the marrow, relative to wild-type animals, and following adoptive transfer, the HO-1−/+ HSC compartment was smaller compared to that of HO-1+/+ in recipient animals. As a consequence, limited numbers of HO-1−/+ BM cells failed to provide adequate radio-protection of lethally irradiated recipients, and HO-1−/+ HSCs showed significantly compromised capacity to serially repopulate myeloablated hosts. We also noted that expression levels of the cyclin-dependent kinase inhibitor p21Cip/WAF1 were lower in lin- HO-1−/+ BM cells in contrast to that in HO-1+/+ cells under steady-state conditions, and that p38 mitogen-activated protein kinase (p38MAPK) was insufficiently activated in HO-1−/+ multipotent progenitors (MPPs) after heme challenge, compared to that in wild-type MPPs. We propose a model wherein HO-1 plays an intracellular regulatory and cyto-protective role in maintaining HSC compartment, especially during stress hematopoiesis. It follows that reduced levels of p38MAPK activation, presumably due to insufficient production of CO when HO-1 is deficient, result in accelerated proliferation of MPPs. This would potentially skew the balance between self-renewal and differentiation of HSC and deplete the primitive cell compartment, leading to ultimate hematopoietic exhaustion.


2016 ◽  
Vol 364 (3) ◽  
pp. 573-584 ◽  
Author(s):  
Patrick Wuchter ◽  
Rainer Saffrich ◽  
Stefan Giselbrecht ◽  
Cordula Nies ◽  
Hanna Lorig ◽  
...  

Blood ◽  
2014 ◽  
Vol 124 (10) ◽  
pp. 1622-1625 ◽  
Author(s):  
Serine Avagyan ◽  
Michael Churchill ◽  
Kenta Yamamoto ◽  
Jennifer L. Crowe ◽  
Chen Li ◽  
...  

Key Points XLF-deficient mice recapitulate the lymphocytopenia of XLF-deficient patients. Premature aging of hematopoietic stem cells underlies the severe and progressive lymphocytopenia in XLF-deficient mice.


2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Huihong Zeng ◽  
Jiaoqi Cheng ◽  
Ying Fan ◽  
Yingying Luan ◽  
Juan Yang ◽  
...  

Development of hematopoietic stem cells is a complex process, which has been extensively investigated. Hematopoietic stem cells (HSCs) in mouse fetal liver are highly expanded to prepare for mobilization of HSCs into the fetal bone marrow. It is not completely known how the fetal liver niche regulates HSC expansion without loss of self-renewal ability. We reviewed current progress about the effects of fetal liver niche, chemokine, cytokine, and signaling pathways on HSC self-renewal, proliferation, and expansion. We discussed the molecular regulations of fetal HSC expansion in mouse and zebrafish. It is also unknown how HSCs from the fetal liver mobilize, circulate, and reside into the fetal bone marrow niche. We reviewed how extrinsic and intrinsic factors regulate mobilization of fetal liver HSCs into the fetal bone marrow, which provides tools to improve HSC engraftment efficiency during HSC transplantation. Understanding the regulation of fetal liver HSC mobilization into the fetal bone marrow will help us to design proper clinical therapeutic protocol for disease treatment like leukemia during pregnancy. We prospect that fetal cells, including hepatocytes and endothelial and hematopoietic cells, might regulate fetal liver HSC expansion. Components from vascular endothelial cells and bones might also modulate the lodging of fetal liver HSCs into the bone marrow. The current review holds great potential to deeply understand the molecular regulations of HSCs in the fetal liver and bone marrow in mammals, which will be helpful to efficiently expand HSCs in vitro.


2012 ◽  
Vol 1266 (1) ◽  
pp. 72-77 ◽  
Author(s):  
Fumio Arai ◽  
Kentaro Hosokawa ◽  
Hirofumi Toyama ◽  
Yoshiko Matsumoto ◽  
Toshio Suda

2020 ◽  
Vol 27 (2) ◽  
pp. 336-345.e4 ◽  
Author(s):  
Samik Upadhaya ◽  
Oleg Krichevsky ◽  
Ilseyar Akhmetzyanova ◽  
Catherine M. Sawai ◽  
David R. Fooksman ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 4034-4034
Author(s):  
Kenji Takahashi ◽  
Satoru Monzen ◽  
Ikuo Kashiwakura

Abstract Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2 (Tie-2) and its ligand, angiopoietin-1 (Ang-1) play an important role in the remodeling and maturation the vessels. However, Tie-2 expressed in hematopoietic stem cells has been reported to interact with Ang-1 on stromal osteoblasts in the bone marrow niche. This interaction leads to tight adhesion of hematopoietic stem cells to stromal cells, resulting in the maintenance of long-term repopulating activity of hematopoietic stem cells. Although the high radio-sensitivity of hematopoietic stem/progenitor cells is a serious cause of radiation damage in accidentally irradiated victims, the relationship of Tie-2/Ang-1-signals relate to radio-sensitivity is unclear. In addition, a diagnosis of specific radio-sensitivity in patients with malignant diseases allows radio- and/or chemo-therapy to be performed more effectively. Therefore, the radio-protection activity and the possible association of to radio-sensitivity in hematopoietic stem/progenitor of Tie-2/Ang-1 signaling was evaluated. This study was approved by the Committee of Medical Ethics of Hirosaki University School of Medicine. CD34+ hematopoietic stem/progenitor cells were isolated using a magnet sorting kit from human placental and umbilical cord blood units (n = 33) at the end of full-term deliveries after obtaining informed consent from the mothers. Each purified CD34+ fraction individually (81.3 ± 13.7%) was analyzed for the expression of Tie-2 using a flow cytometer. The range of Tie-2-expression was 1.6 ∼ 12.4% (mean = 5.13%). Based on the Tie-2-positive rate, all 33 fractions were classified into CD34+/Tie-2low fraction (Tie-2 positive rate; < 5%, n = 17) or CD34+/Tie-2high fraction (Tie-2 positive rate; ≥ 5%, n = 16). The CD34+ cells were exposed to X-rays at 2 Gy by an X-rays generator (150 kVp, 20 mA, 0.8 ∼ 0.95 Gy/min). The radio-sensitivity of the hematopoietic stem/progenitor cells of each specimen was measured using clonogenic assays. Specifically, the BFU-E, CFU-GM and CFU-GEMM of each sample were assessed in triplicate using a 14-day culture assay in a methylcellulose medium with 5 growth factors (EPO; 4 U/ml, SCF and IL-3; 100 ng/ml, G-CSF and GM-CSF; 10 ng/ml). In addition, CFU-Meg was assessed in triplicate using a 14-day plasma clot technique with 2 growth factors (TPO; 50 ng/ml, SCF; 100 ng/ml). Unexpectedly, the total CFC number decreased with the expression of Tie-2 in CD34+ cells and the total CFC number in CD34+/Tie-2high fractions was lower than that of CD34+/Tie-2low fractions. Moreover, the survival of total CFC at 2 Gy and Tie-2-expression were positively correlated in the CD34+ cells and the total CFC number in CD34+/Tie-2high fractions was more resistant to X-rays than that of CD34+/Tie-2low fractions. Furthermore, to clarify the interaction radio-sensitivity and Tie-2-expression, the effect of Ang-1 on the radio-protective activity in X-irradiated CD34+ cells was examined. However, no protective effect was observed. Although previous reports have showed that CD34+/Tie-2+ cells were more primitive than CD34+/Tie-2− cells, these results suggested that Tie-2-expression appeared to enhance the radio-resistant ability of CD34+ cells and that it was a marker for a radio-sensitivity. Since the direct activation by Ang-1 was not associated with the survival of X-irradiated CD34+ cells, another signaling mechanism may thus be involved in the radio-resistance activity of Tie-2.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 814-814
Author(s):  
Hitoshi Takizawa ◽  
Markus G Manz

Abstract Abstract 814 Hematopoietic stem cells (HSCs) are defined by their capacity to self-renew and give rise to all mature cells of hemato-lymphoid system for the lifetime of an individual. To ensure this, HSCs are kept at homeostatic levels in adult bone marrow. Steady-state HSC cycling kinetics have been evaluated by in vivo labeling assay using 5-bromo-2-deoxyuridine (BrdU) (Cheshier et. al., PNAS 1999; Kiel et al., Nature 2007), biotin (Nygren et. al., PLoS ONE 2008) and histon 2B-green fluorescent protein (H2B-GFP) transgenic model systems (Wilson et. al., Cell 2008; Foudi et. al., Nat. Biotech. 2008). Based on the latter, it was suggested that one HSC pool turns over faster than another, dormant pool with very limited divisions during a lifetime. However, the fast cycling HSCs did not have long-term multilineage reconstitution capacity in lethally irradiated animals in contrast to dormant HSCs (Wilson et. al., Cell 2008; Foudi et.al., Nat. Biotech. 2008). From these experiments remained unclear, whether the faster cycling HSC loose long-term repopulation potential according to divisional history, or whether they represent progenitors with limited self-renewal potential, sharing a long-term HSC phenotype. Therefore, the dynamics of steady-state long-term HSC homeostasis and blood production remains to be determined. To address this directly, we set up an in vivo HSC divisional tracking assay. Here we show i.v. transfer of CFSE (carboxyfluorescein diacetate succinimidyl ester) -labeled HSCs into non-conditioned CD45.1/2 congenic F1 recipient mice that allows evaluation of steady-state HSC dynamics as CFSE distributes equally to daughter cells upon each cellular division. Sorted naïve CD4+CD62L+ T cells were used as non-dividing control cell population to determine the zero division CFSE staining level over time. Upon transfer of Lin-c-kit+Sca-1+ cells (LKS) into sublethally irradiated mice, all donor derived Lin-c-kit+ cells had divided >5 times after 3 weeks. However, transfer of LKS cells into non-irradiated mice revealed non-divided LKS cells in recipient bone marrow over 20 weeks. FACS analysis with HSC or progenitor specific marker expression showed that most of 0-2 time-divided and few of >5x divided LKS cells maintained a long-term HSC phenotype (CD150+, c-mpl+, CD34-). In order to test HSC potential, non- or >5x divided cells were sorted based on divisional history from primary recipients at different time points after transplantation, and competitively transplanted into lethally irradiated secondary recipients. At 3 weeks post primary transfer, single non-divided LKS cell was able to multi-lineage repopulate recipients, while 50 of >5x divided LKS cells showed no engraftment. Interestingly, both non- and >5x divided LKS cells at 7 or 12-14 weeks after primary transfer had long-term multilineage repopulating potential. Limiting dilution transplantation experiments demonstrated that HSC with long-term multilineage capacity (LT-HSC) were maintained at constant numbers that fit the numbers of free bone marrow niche space, with non-divided LT-HSC decreasing and >5x divided LT-HSC increasing with a constant division rate. We next tested the effects of hemato-immunological challenge on HSC cycling dynamics. Upon i.p. LPS injection into mice, previously transplanted with CFSE-labeled LKS, almost all LT-HSCs entered cell cycle within one week after challenge. These findings directly demonstrate that some LT-HSCs are quiescent for up to one fifth of the life-time of a mouse, while other LT-HSCs divide more actively, thus proving asynchronous LT-HSC division and contribution to hematopoiesis in steady-state. In addition, the results demonstrate that quiescent LT-HSCs are driven into division in response to naturally-occurring hematopoietic challenges, such as systemic bacterial infection. The CFSE-tracking model established here now allows to directly test the role of intrinsic versus environmental cues on cycling-dynamics of HSCs as well as leukemia initiating cells in steady-state and upon challenge on multiple genetic and different species background. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document